High serum gamma‐glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma DOI
Miyako Murakawa, Mina Nakagawa, Hisaaki Nishimura

et al.

Hepatology Research, Journal Year: 2024, Volume and Issue: unknown

Published: July 29, 2024

Abstract Aim Gamma‐glutamyltransferase (GGT) is known as an oxidative stress marker, induced by alcohol consumption and metabolic disorders, reported a predictor of hepatocellular carcinoma (HCC) development after hepatitis C virus (HCV) elimination. However, it not clear whether GGT serves simply surrogate marker for overlapping diseases or reflects HCV‐specific carcinogenicity. We investigated the association between hepatocarcinogenesis achieving sustained viral response (SVR), accounting drinking habits diabetes, examined predisposing factors associated with levels SVR. Methods This prospective, multicenter, observational study using database 1001 patients HCV eradication direct‐acting antiviral agents. The at SVR cumulative HCC was in multivariate analysis Cox proportional hazard models adjustment covariates including diabetes. markers genetic analyzed. Results High were (HR] 2.38, 95% CI 1.10–5.17). also significant when restricted to without diabetes (HR 8.38, 2.87–24.47). correlated serum growth differentiation factor 15 levels, mitochondrial dysfunction. Single‐nucleotide polymorphisms ZNF827 GDF15 high levels. Conclusions are influenced predisposition may reflect dysfunction eradication.

Language: Английский

MAFLD: what 2 years of the redefinition of fatty liver disease has taught us DOI
Felix Grabherr, Christoph Grander, Maria Effenberger

et al.

Therapeutic Advances in Endocrinology and Metabolism, Journal Year: 2022, Volume and Issue: 13

Published: Jan. 1, 2022

Metabolic dysfunction–associated fatty liver disease (MAFLD) has appeared as the leading worldwide. Whereas terminology nonalcoholic (NAFLD) mainly reflected a negative selection and exclusion of alcohol-related (ALD), new definition made its focus on association MAFLD with overweight/obesity, type 2 diabetes metabolic risk factors especially also in normal weight/lean subjects. Several studies from past years have now used provided substantial information that this might be accurate. Studies evidence advantageous characterization identification patients significant fibrosis. This been demonstrated well-known Rotterdam study which MAFLD-only group showed higher rate fibrosis stiffness. able to predict all-cause mortality Third National Health Nutrition Examination Survey. Furthermore, improve cardiovascular patient population. As term not yet accepted universally, it remains important coordinate efforts globally adapt involve all specialities dealing disorders such diabetologists further prepare medical community for future use. The aim review is summarize critically address emerging over usage could helpful daily clinical practice.

Language: Английский

Citations

9

Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients DOI Open Access
Rubén Martín‐Escolano, Ana Virseda‐Berdices, Juan Berenguer

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2023, Volume and Issue: 164, P. 114913 - 114913

Published: May 19, 2023

Hepatic steatosis is a common condition found in the liver of hepatitis C virus (HCV)-infected patients, contributing to more severe forms disease. In addition, human immunodeficiency (HIV) may accelerate this process. Alternatively, several immune checkpoint proteins have been reported be upregulated and correlated with disease progression during HCV HIV infections. steatosis, detrimental system activation has established; however, role checkpoints not addressed so far. Thus, study aimed evaluate association between plasma at baseline (before antiviral therapy) hepatic index (HSI) increase end follow-up (∼ five years after sustained virologic response (SVR)). We performed multicenter retrospective 62 patients coinfected HIV/HCV who started therapy. Immune were analyzed using Luminex 200TM analyzer. The statistical analysis was carried out Generalized Linear Models (GLM) Partial Least Squares Discriminant Analysis (PLS-DA). Fifty-three percent showed HSI from follow-up. Higher protein levels BTLA, CD137(4-1BB), CD80, GITR, LAG-3, PD-L1 before therapy associated long-term successful therapy, suggesting potential predictive for early detection towards HIV/HCV-coinfected patients.

Language: Английский

Citations

4

The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area DOI
Chung‐Feng Huang, Po‐Cheng Liang, Pei‐Chien Tsai

et al.

Journal of Gastroenterology and Hepatology, Journal Year: 2023, Volume and Issue: 39(1), P. 193 - 201

Published: Sept. 20, 2023

Abstract Background and Aim The prevalence of metabolic dysfunction‐associated fatty liver disease (MAFLD) its interplay with hepatitis B virus (HBV) C (HCV) in terms severity is elusive. Methods A mass surveillance program was conducted a viral endemic area. objective to identify MAFLD/non‐MAFLD subjects advanced disease. Results Two thousand two hundred forty‐two (41.7%) the 5378 were identified as having MAFLD, 375 (7.0%) had proportions anti‐HCV HBsAg seropositivity 19.3% 9.7%, respectively. fibrosis non‐viral (NBNC), HBV HCV infection 2.8%, 5.7% 23.4%, Subjects MAFLD significantly higher proportion (8.7% vs 5.7%, P < 0.001). Factors associated included age (odds ratio [OR]/95% confidence interval [CI]: 4.8/3.7–6.0, 0.001), male sex (OR/CI: 1.3/1.0–1.7, = 0.019), 5.9/4.6–7.5, MAFLD‐lean dysregulation (MS) 2.6/1.3–5.2, 0.005; compared non‐MAFLD group) MAFLD‐diabetes 1.5/1.1–2.1, 0.008; group). did not aggravate patients hepatitis. However, among NBNC subjects, factors MS group 9.1/2.4–34.6, 0.001; MAFLD‐DM 2.0/1.2–3.2, 0.004; Conclusions diabetes risk effect more significant community level.

Language: Английский

Citations

4

A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact DOI Open Access
Ziyan Pan,

Wai‐Kay Seto,

Chun‐Jen Liu

et al.

HepatoBiliary Surgery and Nutrition, Journal Year: 2024, Volume and Issue: 13(4), P. 650 - 661

Published: April 22, 2024

Hepatocellular carcinoma (HCC) poses a significant global health burden and ranks as the fifth most prevalent cancer on scale. Hepatitis C virus (HCV) infection remains one of major risk factors for HCC development. is heterogeneous disease, development caused by HCV intricate involves various factors, including genetic susceptibility, viral immune response due to chronic inflammation, alcohol abuse, metabolic dysfunction associated with fatty liver disease. In this review, we provide comprehensive updated review research genetics epigenetic mechanisms implicated in developing infection. We also discuss potential translational implications, novel biomarkers drugs treatment.

Language: Английский

Citations

1

High serum gamma‐glutamyltransferase level after hepatitis C virus elimination is a risk factor for the development of hepatocellular carcinoma DOI
Miyako Murakawa, Mina Nakagawa, Hisaaki Nishimura

et al.

Hepatology Research, Journal Year: 2024, Volume and Issue: unknown

Published: July 29, 2024

Abstract Aim Gamma‐glutamyltransferase (GGT) is known as an oxidative stress marker, induced by alcohol consumption and metabolic disorders, reported a predictor of hepatocellular carcinoma (HCC) development after hepatitis C virus (HCV) elimination. However, it not clear whether GGT serves simply surrogate marker for overlapping diseases or reflects HCV‐specific carcinogenicity. We investigated the association between hepatocarcinogenesis achieving sustained viral response (SVR), accounting drinking habits diabetes, examined predisposing factors associated with levels SVR. Methods This prospective, multicenter, observational study using database 1001 patients HCV eradication direct‐acting antiviral agents. The at SVR cumulative HCC was in multivariate analysis Cox proportional hazard models adjustment covariates including diabetes. markers genetic analyzed. Results High were (HR] 2.38, 95% CI 1.10–5.17). also significant when restricted to without diabetes (HR 8.38, 2.87–24.47). correlated serum growth differentiation factor 15 levels, mitochondrial dysfunction. Single‐nucleotide polymorphisms ZNF827 GDF15 high levels. Conclusions are influenced predisposition may reflect dysfunction eradication.

Language: Английский

Citations

1